Blood Preparation Market by Product (Whole Blood, Blood Components, and Blood Derivatives); By Type (Platelet Aggregation Inhibitors, Fibri…

Blood Preparation Market by Product (Whole Blood, Blood Components, and Blood Derivatives); By Type (Platelet Aggregation Inhibitors, Fibrinolytics, and Anticoagulants); By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026

  • SKU :
    SAC2034391
  • Published Date :
    Aug. 1, 2018
  • Number of Pages :
    121.0

Product Description

The research report offers a comprehensive picture of the Blood Preparation market. The report initiates with the executive summary of the market that includes market definition, recent industry trends, and developments, strategies of the key players and wide product offerings. Moreover, the study explains the future opportunities and a sketch of the key participants actively operating in the market.

About Blood Preparation Market

The Global Blood Preparation market was approximately valued $41.2 billion at 2018, with a projected CAGR of 4.7% during the forecast period. Blood components are products derived from platelet rich plasma or whole blood. It is a procedure in which one unit of whole blood goes through centrifugation. It is carried out in specialized equipment known as a refrigerated centrifuge. The growing demand for blood transfusion amongst emergency departments in hospitals, rise in blood disorders such as thrombocytosis and the snowballing requirement for blood during accidents and surgical procedures are the major factors driving the growth of the global blood preparation market. However, during blood transfusion, the chances of transmission of diseases such as viral hemorrhagic fever, HIV, and Hepatitis B are high which may hamper the market from growing. 

The research report is prepared based on the combination of qualitative as well as quantitative aspects. By thorough understanding, the report is fragmented by larger ratios. The report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market. On the other hand, The Blood Preparation report presents data starting from the base year 2018, historical year: 2014-2018, estimated the year 2020 and Forecast year from 2019 to 2026.

The Blood Preparation market report offers the market size and estimates the forecast from 2019-2026. The forecast estimation is predicted based on the key regions that include North America, Europe, Asia Pacific, Middle East, South America, and the Middle East & Africa. Furthermore, the Blood Preparation report provides a deep emphasis on secondary tools used to document the report. PEST analysis, SWOT, Porter’s Five Forces, and others are considered by the analysts while preparing the report.

Scope and Segmentation of the Market

Based on Type


Platelet Aggregation Inhibitors
ADP Inhibitors
Glycoprotein Inhibitors
COX Inhibitors
Others
  Fibrinolytics
Streptokinase
Urokinase
Tissue Plasminogen Activator (tPA)
  Anticoagulants
Heparins
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors
Vitamin K Antagonists

Based on Application

Thrombocytosis
Pulmonary Embolism
Infectious Disease
Angina Blood Vessel Complications
Other Applications

Each segment of the Blood Preparation market is extensively evaluated in the research study. The segment analysis covered in the report aims at the key opportunities available in the Blood Preparation market report by leading segments. In addition, the research report offers market dynamics for the market that influences qualitative as well as quantitative research.

Research Methodology

The report follows a comprehensive and rigorous research methodology to provide you accurate estimates and forecasts of a particular market. The report provide estimates, forecast, and analysis primarily based on secondary research, primary interviews, in-house database and other free as well as paid sources. In addition, the research methodology we follow is a systematic approach in order to estimate and project the market sizing keeping in mind all the ongoing and upcoming trends of the market.

Competitive Landscape

Key players profiled in this report include (Sales Revenue, Price, Gross Margin, Main Products, etc.):

AstraZeneca Co
Baxter Healthcare Corp.
Bristol-Myers Squibb Co.
Celgene Corp
GlaxoSmithKline PLC
Leo Pharma Inc.
Pfizer Inc.
Sanofi Aventis
Shandong East Chemical Industry Co.

Through the successive chapters on the company, profiles provide deep insights on players operating in the Blood Preparation market. It focuses on the financial outlook of the key players, the status of R&D, strategies adopted, expansion strategies, and many more. Analysts preparing the report have offered a detailed list of the strategic initiatives adopted by the Blood Preparation market participants by referring past records and designing strategies to be adopted in the coming years. This enables the key players to stay ahead in the competition.

Regional Landscape

The chapter on regional segmentation details the regional aspects of the Blood Preparation market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Blood Preparation market. Moreover, the report focuses on value and volume at the regional level, company level, and level.

Chapters covered under this report include:

Chapter 1, describes the Blood Preparation market reports - market overview, executive summary, and market scope. Further, the report adds a support base to identify the information and pick in relation to the aforementioned market

Chapter 2, defines the research methodology based on primary as well as secondary research, secondary data sources, and assumptions & exclusions

Chapter 3, description of Blood Preparation market in terms of its product scope, opportunities, drivers, restraints, and market risks

Chapter 4, the report offers a company profile of the top manufacturers of Blood Preparation market with its sales, revenue, share, and others

Chapter 5 and 6, to narrow down the sales data at the country level with shares, revenue, sand sales from 2018-2026

Chapter 7, the Blood Preparation market data is published based on a regional level and to show the revenue, sales, and growth on basis of the base year 2018, historical year: 2014-2018, estimated the year 2020 and Forecast year from 2019 to 2026

Chapter 8, describes the Blood Preparation market sales channels, distributors, research findings, appendix, and among others.

Table of Content

TABLE OF CONTENTS

Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Market Scope

Chapter 2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources

Chapter 3 Market Overview
3.1 Report Segmentation & Scope
3.2 Key Market Trends
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis
3.4 Market Share Analysis

Chapter 4 Global Blood Preparation Market by Product: Market Size and Forecast, 2018 – 2026
4.1 Introduction
4.1.1 Market Size and Forecast
4.2 Whole Blood
4.2.1 Market Size and Forecast
4.2.2 Red Cells
4.2.2.1 Market Size and Forecast
4.2.3 Plasma
4.2.3.1 Market Size and Forecast
4.2.4 Platelets
4.2.4.1 Market Size and Forecast
4.2.5 Granulocytes
4.2.5.1 Market Size and Forecast
4.3 Blood Components
4.3.1 Market Size and Forecast
4.3.2 Packed Red Cells
4.3.2.1 Market Size and Forecast
4.3.3 Frozen Plasma
4.3.3.1 Market Size and Forecast
4.3.4 Whole Blood Components
4.3.4.1 Market Size and Forecast
4.3.5 Platelet Concentrate
4.3.5.1 Market Size and Forecast
4.3.6 Leukocyte Reduced Red Blood Cells
4.3.6.1 Market Size and Forecast
4.4 Blood Derivative
4.4.1 Market Size and Forecast

Chapter 5 Global Blood Preparation Market by Type: Market Size and Forecast, 2018 – 2026
5.1 Introduction
5.1.1 Market Size and Forecast
5.2 Platelet Aggregation Inhibitors
5.2.1 Market Size and Forecast
5.2.2 ADP Inhibitors
5.2.2.1 Market Size and Forecast
5.2.3 Glycoprotein Inhibitors
5.2.3.1 Market Size and Forecast
5.2.4 COX Inhibitors
5.2.4.1 Market Size and Forecast
5.2.5 Others
5.2.5.1 Market Size and Forecast
5.3 Fibrinolytics
5.3.1 Market Size and Forecast
5.3.2 Streptokinase
5.3.2.1 Market Size and Forecast
5.3.3 Urokinase
5.3.3.1 Market Size and Forecast
5.3.4 Tissue Plasminogen Activator (tPA)
5.3.4.1 Market Size and Forecast
5.4 Anticoagulants
5.4.1 Market Size and Forecast
5.4.2 Heparins
5.4.2.1 Market Size and Forecast
5.4.3 Direct Thrombin Inhibitors
5.4.3.1 Market Size and Forecast
5.4.4 Direct Factor Xa Inhibitors
5.4.4.1 Market Size and Forecast
5.4.5 Vitamin K Antagonists
5.4.5.1 Market Size and Forecast

Chapter 6 Global Blood Preparation Market by Application: Market Size and Forecast, 2018 – 2026
6.1 Introduction
6.1.1 Market Size and Forecast
6.2 Thrombocytosis
6.2.1 Market Size and Forecast
6.3 Pulmonary Embolism
6.3.1 Market Size and Forecast
6.4 Infectious Disease
6.4.1 Market Size and Forecast
6.5 Angina Blood Vessel Complications
6.5.1 Market Size and Forecast
6.6 Other Applications
6.6.1 Market Size and Forecast

Chapter 7 Global Blood Preparation Market by Geography: Market Size and Forecast, 2018 – 2026
7.1 Introduction
7.1.1 Market Size and Forecast
7.2 North America
7.2.1 North America Market Size & Forecast, By Country
7.2.2 North America Market Size & Forecast, By Product
7.2.3 North America Market Size & Forecast, By Type
7.2.4 North America Market Size & Forecast, By Application
7.2.5 The U.S.
7.2.5.1 Market Size and Forecast
7.2.6 Canada
7.2.6.1 Market Size and Forecast
7.2.7 Mexico
7.2.7.1 Market Size and Forecast
7.3 Europe
7.3.1 Europe Market Size and Forecast, By Country
7.3.2 Europe Market Size and Forecast, By Product
7.3.3 Europe Market Size and Forecast, By Type
7.3.4 Europe Market Size and Forecast, By Application
7.3.5 UK
7.3.5.1 Market Size and Forecast
7.3.6 Germany
7.3.6.1 Market Size and Forecast
7.3.7 France
7.3.7.1 Market Size and Forecast
7.3.8 Italy
7.3.8.1 Market Size and Forecast
7.3.9 Spain
7.3.9.1 Market Size and Forecast
7.3.10 Rest of Europe
7.3.10.1 Market Size and Forecast
7.4 Asia-Pacific
7.4.1 Asia-Pacific Market Size and Forecast, By Country
7.4.2 Asia-Pacific Market Size and Forecast, By Product
7.4.3 Asia-Pacific Market Size and Forecast, By Type
7.4.4 Asia-Pacific Market Size and Forecast, By Application
7.4.5 India
7.4.5.1 Market Size and Forecast
7.4.6 China
7.4.6.1 Market Size and Forecast
7.4.7 Australia
7.4.7.1 Market Size and Forecast
7.4.8 Japan
7.4.8.1 Market Size and Forecast
7.4.9 South Korea
7.4.9.1 Market Size and Forecast
7.4.10 Rest of Asia-Pacific
7.4.10.1 Market Size and Forecast
7.5 South America
7.5.1 South America Market Size and Forecast, By Country
7.5.2 South America Market Size and Forecast, By Product
7.5.3 South America Market Size and Forecast, By Type
7.5.4 South America Market Size and Forecast, By Application
7.5.5 Brazil
7.5.5.1 Market Size and Forecast
7.5.6 Rest of South America
7.5.6.1 Market Size and Forecast
7.6 RoW
7.6.1 RoW Market Size and Forecast, By Country
7.6.2 RoW Market Size and Forecast, By Product
7.6.3 RoW Market Size and Forecast, By Type
7.6.4 RoW Market Size and Forecast, By Application
7.6.5 Middle East
7.6.5.1 Market Size and Forecast
7.6.6 Africa
7.6.6.1 Market Size and Forecast

Chapter 8 Company Profiles
8.1 AstraZeneca Co
8.2 Baxter Healthcare Corp.
8.3 Bristol-Myers Squibb Co.
8.4 Celgene Corp
8.5 GlaxoSmithKline PLC
8.6 Leo Pharma Inc.
8.7 Pfizer Inc.
8.8 Sanofi Aventis
8.9 Shandong East Chemical Industry Co.

Search results for Pharmaceutical Industry